These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 7781437

  • 1. Exacerbation of primary biliary cirrhosis during interferon-alpha 2b therapy for chronic active hepatitis C.
    Maeda T, Onishi S, Miura T, Iwamura S, Tomita A, Saibara T, Yamamoto Y.
    Dig Dis Sci; 1995 Jun; 40(6):1226-30. PubMed ID: 7781437
    [Abstract] [Full Text] [Related]

  • 2. A randomized controlled trial of recombinant interferon-alpha in chronic hepatitis C in hemophiliacs.
    Makris M, Preston FE, Triger DR, Underwood JC, Westlake L, Adelman MI.
    Blood; 1991 Oct 01; 78(7):1672-7. PubMed ID: 1912556
    [Abstract] [Full Text] [Related]

  • 3. [A case of primary biliary cirrhosis associated with chronic active hepatitis type C improved by the injection of interferon and the administration of ursodeoxycholic acid].
    Saitoh S, Yamada T, Satoh K, Makita F, Ojima T, Nishijima K, Chishima J, Yamada S, Takagi H, Nagamine T.
    Nihon Shokakibyo Gakkai Zasshi; 1993 Sep 01; 90(9):2152-6. PubMed ID: 8411755
    [No Abstract] [Full Text] [Related]

  • 4. Treatment of chronic hepatitis C by continuous subcutaneous infusion of interferon-alpha.
    Carreño V, Tapia L, Ryff JC, Quiroga JA, Castillo I.
    J Med Virol; 1992 Jul 01; 37(3):215-9. PubMed ID: 1331310
    [Abstract] [Full Text] [Related]

  • 5. [Treatment with interferon alfa-2b in patients with chronic hepatitis caused by hepatitis C virus: predictive factors for the response, relapse and early development to cirrhosis after treatment].
    Pérez Roldán F, De Diego A, Casado M, Matilla A, Bañares R, García-Durán F, Salcedo M, Cos E, Clemente G.
    Rev Esp Enferm Dig; 1996 Sep 01; 88(9):609-15. PubMed ID: 8962775
    [Abstract] [Full Text] [Related]

  • 6. Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis.
    Nishiguchi S, Kuroki T, Nakatani S, Morimoto H, Takeda T, Nakajima S, Shiomi S, Seki S, Kobayashi K, Otani S.
    Lancet; 1995 Oct 21; 346(8982):1051-5. PubMed ID: 7564784
    [Abstract] [Full Text] [Related]

  • 7. alpha-Interferon treatment of chronic hepatitis C in young patients with homozygous beta-thalassemia.
    Di Marco V, Lo Iacono O, Capra M, Grutta S, Ciaccio C, Gerardi C, Maggio A, Renda D, Almasio P, Pisa R.
    Haematologica; 1992 Oct 21; 77(6):502-6. PubMed ID: 1289187
    [Abstract] [Full Text] [Related]

  • 8. The use of recombinant interferon alfa-2b in elderly patients with anti-HCV-positive chronic active hepatitis.
    Bresci G, Del Corso L, Romanelli AM, Giuliano G, Pentimone F.
    J Am Geriatr Soc; 1993 Aug 21; 41(8):857-62. PubMed ID: 7688007
    [Abstract] [Full Text] [Related]

  • 9. Dose increase augments response rate to interferon-alpha in chronic hepatitis C.
    Ferenci P, Stauber R, Propst A, Fiedler R, Müller C, Gschwantler M, Schütze K, Datz C, Judmaier G, Vogel W, Krejs GJ, Gangl A.
    Dig Dis Sci; 1996 Dec 21; 41(12 Suppl):103S-108S. PubMed ID: 9011466
    [Abstract] [Full Text] [Related]

  • 10. Chronic hepatitis C complicated by Coombs-negative hemolytic anemia during interferon treatment.
    Hirashima N, Mizokami M, Orito E, Yamauchi M, Narita M, Mizuno M, Tokuda Y, Nakano T, Kato M, Matsumoto T.
    Intern Med; 1994 May 21; 33(5):300-2. PubMed ID: 7949634
    [Abstract] [Full Text] [Related]

  • 11. Primary biliary cirrhosis induced by interferon-alpha therapy for hepatitis C virus infection.
    D'Amico E, Paroli M, Fratelli V, Palazzi C, Barnaba V, Callea F, Consoli G.
    Dig Dis Sci; 1995 Oct 21; 40(10):2113-6. PubMed ID: 7587775
    [Abstract] [Full Text] [Related]

  • 12. Exacerbation of lichen planus during interferon alfa-2a therapy for chronic active hepatitis C.
    Protzer U, Ochsendorf FR, Leopolder-Ochsendorf A, Holtermüller KH.
    Gastroenterology; 1993 Mar 21; 104(3):903-5. PubMed ID: 8440441
    [Abstract] [Full Text] [Related]

  • 13. [A comparative randomized controlled study of the efficacy of interferon alfa-2b and interferon alfa-2a in the treatment of chronic hepatitis C].
    Fernández I, Castellano G, Canga F, Colina F, García H, Fuertes A, Casis B, Martín A, Solís JA.
    Gastroenterol Hepatol; 1995 Feb 21; 18(2):66-72. PubMed ID: 7621277
    [Abstract] [Full Text] [Related]

  • 14. Long-term efficacy of interferon-alpha and ursodeoxycholic acid in treatment of chronic type C hepatitis.
    Senturk H, Uzunalimoglu O, Batur Y, Simsek I, Mert A, Ozbay G, Cetinkaya H, Ersoz G, Tabak F, Akbaylar H, Akdogan M, Dokmeci A, Sonsuz A, Ozenirler S, Erden E, Tozum N.
    Dig Dis Sci; 1997 Jul 21; 42(7):1438-44. PubMed ID: 9246043
    [Abstract] [Full Text] [Related]

  • 15. Association of response to combined interferon alpha-2b and ribavirin therapy in patients of chronic hepatitis c with serum alanine aminotransferase levels and severity of the disease on liver biopsy.
    Nadeem A, Hussain MM, Aslam M, Hussain T, Butt IF, Ali Khan S, Asad A.
    J Ayub Med Coll Abbottabad; 2009 Jul 21; 21(2):103-6. PubMed ID: 20524482
    [Abstract] [Full Text] [Related]

  • 16. A controlled study to determine the optimal dose regimen of interferon-alpha 2b in chronic hepatitis C.
    Hakozaki Y, Shirahama T, Katou M, Nakagawa K, Oba K, Mitamura K.
    Am J Gastroenterol; 1995 Aug 21; 90(8):1246-9. PubMed ID: 7639224
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of different regimens of interferon alfa-2b treatment in chronic hepatitis C.
    De Bac C, Grimaldi F, Clementi C, Duca F, Livoli D, Taliani G.
    Gut; 1993 Aug 21; 34(2 Suppl):S135. PubMed ID: 8314480
    [Abstract] [Full Text] [Related]

  • 18. [Interferon therapy in hepatitis C].
    Ferenci P.
    Wien Med Wochenschr; 1993 Aug 21; 143(16-17):461-4. PubMed ID: 8273373
    [Abstract] [Full Text] [Related]

  • 19. Transforming growth factor beta 1: in situ expression in the liver of patients with chronic hepatitis C treated with alpha interferon.
    Bedossa P, Poynard T, Mathurin P, Lemaigre G, Chaput JC.
    Gut; 1993 Aug 21; 34(2 Suppl):S146-7. PubMed ID: 8314486
    [Abstract] [Full Text] [Related]

  • 20. Interferon alfa for chronic hepatitis C in haemophiliacs.
    Makris M, Preston FE, Triger DR, Underwood JC, Westlake L, Adelman MI.
    Gut; 1993 Aug 21; 34(2 Suppl):S121-3. PubMed ID: 8314476
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.